Polaris Capital Management, LLC Harmony Biosciences Holdings, Inc. Transaction History
Polaris Capital Management, LLC
- $1.83 Billion
- Q3 2024
A detailed history of Polaris Capital Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Polaris Capital Management, LLC holds 45,000 shares of HRMY stock, worth $1.74 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
45,000
Previous 28,500
57.89%
Holding current value
$1.74 Million
Previous $859,000
109.2%
% of portfolio
0.1%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
246Shares Held
45.5MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$434 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$226 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$134 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$101 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.1 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.29B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...